(Q50589394)

16 March 2018

title

Therapy of chronic hepatitis B with a 6-month course of ribavirin (English)

1 reference

16 March 2018

1 reference

1 reference

1 reference

M W Fried

1

1 reference

16 March 2018

T L Fong

2

1 reference

16 March 2018

M G Swain

3

1 reference

16 March 2018

Y Park

4

1 reference

16 March 2018

M P Beames

5

1 reference

16 March 2018

S M Banks

6

1 reference

16 March 2018

J H Hoofnagle

7

1 reference

16 March 2018

A M Di Bisceglie

8

1 reference

16 March 2018

publication date

1 August 1994

1 reference

16 March 2018

published in

Journal of Hepatology

1 reference

16 March 2018

volume

21

1 reference

16 March 2018

issue

2

1 reference

16 March 2018

page(s)

145-150

1 reference

16 March 2018

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

Lassa fever. Effective therapy with ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

Ribavirin treatment for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

A pilot study of ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

A pilot study of 2',3'-dideoxyinosine for the treatment of chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

Molecular mechanisms of action of ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

Trial of ribavirin for the treatment of HBsAg positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

A phase 1 study of ribavirin in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

Hematological and bone marrow effects of ribavirin in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

Effects of ribavirin on red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980387-3

7 January 2021

10.1016/S0168-8278(05)80387-3

Identifiers

DOI

1 reference

16 March 2018

1 reference

16 March 2018